SIC 8071 – Medical Laboratories
| Valuation | |
|---|---|
| Market Cap ($M) | 13.73 |
| Enterprise Value ($M) | 12.82 |
| Book Value ($M) | 5.45 |
| Book Value / Share | 0.92 |
| Price / Book | 2.52 |
| NCAV ($M) | 1.66 |
| NCAV / Share | 0.28 |
| Price / NCAV | 8.28 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.43 |
| Return on Assets (ROA) | -0.21 |
| Return on Equity (ROE) | -0.40 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.59 |
| Current Ratio | 1.59 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.05 |
| Assets | 9.84 |
| Liabilities | 4.39 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Kamin Peter | 11.10 | 3.68 | |
| 13G/A | Renaissance Technologies Llc | 4.58 | -8.57 | |
| 13G/A | Kubacki Raymond C Jr | 4.30 | -35.02 | |
| 13G | Powell Anderson Capital Lp | 5.58 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,036 | 61,177 | 6.60 | |
| 230 | 23,277 | 0.99 | |
| 147 | 14,140 | 1.04 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BGLC – BioNexus Gene Lab Corp. | CELC – Celcuity Inc. |
| EXAS – Exact Sciences Corporation | MDXH – MDxHealth SA |
| VRDN – Viridian Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io